Literature DB >> 21099150

Comparison of two electroretinography systems used in dogs: the HMsERG and the RETIport.

Man Bok Jeong1, Won Gyun Son, Young Woo Park, Se Eun Kim, Shin Ae Park, Kang Moon Seo.   

Abstract

The purpose of the study was to compare two different electroretinography (ERG) instruments used on the same animal in a laboratory setting. Retinal function in both eyes of 12 healthy miniature schnauzers was evaluated under general anesthesia. Scotopic and photopic ERGs were recorded by the HMsERG and the RETIport using the Dog Standard Protocol recommended by the European College of Veterinary Ophthalmologists (ECVO). The waveforms of the ERGs obtained by the two ERG units were similar to those described in previous studies. The 90% reference ranges using the multiple of medians (MoM) showed that the changes in ERG parameters obtained by the HMsERG unit were very similar to those of the RETIport for most ERG responses, except for a few. The results demonstrate that the two ERG systems are comparable for evaluating retinal function in dogs. Further, the results also show that it is necessary to establish ERG system-specific limits of normality in each laboratory or clinic in order to obtain a correct diagnosis, for example by using a graphical representation of the 90% reference range.

Entities:  

Mesh:

Year:  2010        PMID: 21099150     DOI: 10.1292/jvms.10-0197

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  2 in total

1.  Consecutive unilateral recording of the two eyes affects dark-adapted ERG responses, when compared to simultaneous bilateral recording.

Authors:  Maya Ross; Hen Honig; Raaya Ezra-Elia; Eyal Banin; Alexey Obolensky; Edward Averbukh; Alexander Rosov; Elisha Gootwine; Ron Ofri
Journal:  Doc Ophthalmol       Date:  2018-11-09       Impact factor: 2.379

2.  Electroretinography in dogs using a fiber electrode prototype.

Authors:  A L Pereira; F Montiani-Ferreira; V R Santos; S R Salomão; C Souza; A Berezovsky
Journal:  Braz J Med Biol Res       Date:  2013-03-19       Impact factor: 2.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.